Mayinglong Pharmaceutical Group Co., Ltd. (SHA:600993)
China
· Delayed Price · Currency is CNY 26.11
+0.21 (0.81%)
Apr 29, 2026, 3:00 PM CST
SHA:600993 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 11,255 | 12,070 | 11,255 | 10,423 | 9,742 | 12,397 | Upgrade
|
| Market Cap Growth | 6.92% | 7.24% | 7.98% | 6.99% | -21.42% | 42.80% | Upgrade
|
| Enterprise Value | 8,939 | 9,656 | 8,616 | 8,279 | 7,569 | 10,698 | Upgrade
|
| Last Close Price | 26.11 | 28.00 | 25.55 | 23.31 | 21.49 | 26.92 | Upgrade
|
| PE Ratio | 19.05 | 20.76 | 21.31 | 23.52 | 20.36 | 26.68 | Upgrade
|
| Forward PE | 14.47 | 21.80 | 21.80 | 21.80 | 21.80 | 21.80 | Upgrade
|
| PS Ratio | 2.88 | 3.12 | 3.02 | 3.32 | 2.76 | 3.66 | Upgrade
|
| PB Ratio | 2.38 | 2.67 | 2.68 | 2.69 | 2.69 | 3.74 | Upgrade
|
| P/TBV Ratio | 2.52 | 2.85 | 2.85 | 2.88 | 2.84 | 3.99 | Upgrade
|
| P/FCF Ratio | 18.88 | 25.09 | 38.31 | 29.30 | 36.51 | 23.30 | Upgrade
|
| P/OCF Ratio | 16.41 | 20.10 | 22.62 | 17.26 | 28.50 | 20.76 | Upgrade
|
| PEG Ratio | 0.80 | 2.64 | 2.64 | 2.64 | 2.64 | 2.64 | Upgrade
|
| EV/Sales Ratio | 2.29 | 2.50 | 2.31 | 2.64 | 2.14 | 3.16 | Upgrade
|
| EV/EBITDA Ratio | 11.82 | 13.10 | 13.85 | 19.07 | 13.99 | 21.61 | Upgrade
|
| EV/EBIT Ratio | 13.23 | 14.42 | 14.90 | 21.52 | 15.32 | 23.60 | Upgrade
|
| EV/FCF Ratio | 14.99 | 20.07 | 29.33 | 23.28 | 28.36 | 20.11 | Upgrade
|
| Debt / Equity Ratio | 0.02 | 0.02 | 0.06 | 0.07 | 0.18 | 0.06 | Upgrade
|
| Debt / EBITDA Ratio | 0.14 | 0.13 | 0.36 | 0.59 | 1.11 | 0.35 | Upgrade
|
| Debt / FCF Ratio | 0.18 | 0.21 | 0.80 | 0.77 | 2.39 | 0.34 | Upgrade
|
| Net Debt / Equity Ratio | -0.52 | -0.55 | -0.70 | -0.72 | -0.74 | -0.75 | Upgrade
|
| Net Debt / EBITDA Ratio | -3.28 | -3.38 | -4.70 | -6.40 | -4.93 | -5.04 | Upgrade
|
| Net Debt / FCF Ratio | -4.12 | -5.19 | -9.95 | -7.81 | -10.00 | -4.69 | Upgrade
|
| Asset Turnover | 0.71 | 0.73 | 0.75 | 0.63 | 0.77 | 0.85 | Upgrade
|
| Inventory Turnover | 7.43 | 6.57 | 7.25 | 6.00 | 6.27 | 6.94 | Upgrade
|
| Quick Ratio | 4.52 | 4.43 | 4.54 | 5.03 | 4.38 | 4.43 | Upgrade
|
| Current Ratio | 5.06 | 4.96 | 4.94 | 5.54 | 4.92 | 5.05 | Upgrade
|
| Return on Equity (ROE) | 13.45% | 13.90% | 13.59% | 12.07% | 13.83% | 15.14% | Upgrade
|
| Return on Assets (ROA) | 7.62% | 7.88% | 7.22% | 4.85% | 6.70% | 7.09% | Upgrade
|
| Return on Invested Capital (ROIC) | 26.95% | 34.70% | 40.72% | 32.51% | 47.99% | 49.86% | Upgrade
|
| Return on Capital Employed (ROCE) | 13.80% | 14.30% | 13.20% | 9.30% | 11.70% | 13.10% | Upgrade
|
| Earnings Yield | 5.25% | 4.82% | 4.69% | 4.25% | 4.91% | 3.75% | Upgrade
|
| FCF Yield | 5.30% | 3.99% | 2.61% | 3.41% | 2.74% | 4.29% | Upgrade
|
| Dividend Yield | 2.39% | - | 2.43% | 1.72% | 1.63% | 1.30% | Upgrade
|
| Payout Ratio | 45.64% | 46.37% | 33.57% | 36.71% | 34.49% | 26.80% | Upgrade
|
| Buyback Yield / Dilution | -0.17% | -0.32% | 0.23% | 0.19% | -0.22% | 0.43% | Upgrade
|
| Total Shareholder Return | 2.22% | -0.32% | 2.66% | 1.90% | 1.40% | 1.73% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.